Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
View/Download PDF

Translate this page into:

Original Article
14 (
02
); 157-163
doi:
10.1055/s-0042-1756184

Assessment of Psychological Distress Among Indian Adolescents and Young Adults with Solid Cancer Using the National Comprehensive Cancer Network Distress Thermometer

Department of Medical Oncology, Sri Aurobindo Institute of Medical Sciences, Indore, Madhya Pradesh, India
Department of Radiology, CHL Hospital, Indore, Madhya Pradesh, India
Department of Medical Oncology, Sri Aurobindo Institute of Medical Sciences, Indore, Madhya Pradesh, India
Author image
Corresponding author: Shiv Prasad Shrivastava, Indore 453555, Madhya Pradesh, India. drsp2001@yahoo.com
Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Abstract

Purpose

The incidence of cancer has increased in India with a visible impact on the young population (aged 15–39 years). The present study aims to evaluate psychological distress among Indian adolescents and young adults (AYAs) with solid cancer using the National Comprehensive Cancer Network (NCCN) distress thermometer.

Methods

The demographic and clinical characteristics of AYAs patients (age 15–39 years) with cancer were recorded. Assessment of psychological distress of patients using the NCCN distress thermometer was performed at three time points over a period of 3 months. Distress thermometer scale and a self-administered questionnaire in English and Hindi languages was handed over to participants at three time points: at treatment commencement (T1), at 1 month, and 3 months (T2 and T3, respectively) into therapy.

Results

Of the 259 patients, 63% were women and 37% men; the median age was 34 years. In total, 71 (27%) were ≤ 24 years old and 188 (73%) were>24 years old. Bone sarcoma (39%) was common cancer in AYA patients aged ≤ 24 years and breast cancer (21%) in >24 years of age. The distress scores in both the groups were the highest at diagnosis (T1) followed by that measured at 1 (T2) and 3 months (T3) after diagnosis. The distress score in the age ≤ 24 years was the highest (6.7) at T1, followed by those measured at T2 (2.6) and T3 (1.1) and among age>24 years was the highest (6.6) at T1, followed by those measured at T2 (2.6) and T3 (1.2). Among AYA patients>24 years old, worry, nervousness, sadness, transportation, and sleep were the top five identified problems and in ≤ 24 years old, the top identified problems were worry, financial support, sleep, nervousness, and sadness.

Conclusion

Adolescents and young adults experience some level of distress associated with the cancer diagnosis, effects of the disease, treatment regardless of the stage and various transitions throughout the trajectory of the disease. The distress thermometer is an easy and useful tool for the assessment of psychological distress in AYA cancers. Early identification of distress burden with the distress thermometer leads to effective interventions in patients with cancer which could improve outcomes including survival in AYAs with cancer in India.

Keywords

PubMed

Introduction

The annual burden of cancer cases in India has increased with a significant impact on the young population. Adolescent and young adults (AYAs) have been considered as a different group since mid-1990s considering their different needs.1 As per recent reports from India, the incidence of cancer is increasing in younger age groups.23

As per the Global Burden of Diseases 2019 AYA Cancer Collaborators Report, there were ∼1.19 million new cancer cases and 396,000 cancer deaths among AYAs aged 15 to 39 years.4 Cancer is a common cause of mortality in the AYAs.5

The most commonly diagnosed cancers in AYAs are breast cancer, germ cell tumor, sarcomas, lymphoma, brain tumor, cervical carcinoma, colorectal and thyroid cancer.6

Cancer in early adult life is associated with infertility, sexual dysfunction, cardiovascular disease and a second cancer.78910

AYA cancer patients of 15 to 39 years encounter more anxiety, depression, psychological distress, and face difficulty in getting knowledge of cancer, treatment, and stress related to this as compared with contemporaries living without cancer.11 The psychological distress due to treatment and toxicities can result in loss of school, altered social profile, distorted relationships, high expenses, poor sexual life, and poor survival.12 Studies reported that most of the adult patients diagnosed with cancer suffer from disease- or treatment-related adverse effects. The cancer-related distress was defined as an unpleasant experience of a psychological, social, spiritual, and physical symptoms that may interfere with the ability to cope effectively with cancer treatment.13

Routine distress screening was recommended by the National Comprehensive Cancer Network (NCCN) in 2007, with the development of a screening tool to assess distress in adult cancer patients; the NCCN distress thermometer (DT) and problem checklist (PCL).14

The psychosocial morbidity can be measured using tools to monitor the health-related quality of life (HRQOL). Interventions can be planned after factoring in the poor psychological outcomes.15

A few epidemiological studies have utilized a standardized screening tool to evaluate psychological distress changes among AYAs with cancer.1617 This study aims to assess psychological distress across three time points over a 3-month period after the diagnosis.

Materials and Methods

Study Design

A prospective, cross-sectional study on AYA cancer patients was conducted between September 2020 and August 2021 at Sri Aurobindo Institute Medical Sciences (SAIMS) Indore, India. International Conference on Harmonization-Good Clinical Practices (ICH-GCP) and the applicable legislation on non-interventional studies were followed in this study. Distress Thermometer scale and a self-administered questionnaire in English and Hindi languages were handed over to participants at the time of diagnosis or treatment commencement (T1), at 1 month (T2) and 3 months (T3) during the period of treatment. Patients were explained and asked to mark the number on a scale of 0 to 10 to show their distress level. If the patient's distress level is 4 or higher, oncology team member will look at the NCCN DT problem list. The study protocol was approved by the Institutional Ethics Committee (IEC No. SAIMS/IEC/2021/21). Informed consent before study participation was obtained. Patients younger than 18 years were ascent-consented by their legal guardians.

Inclusion and Exclusion Criteria

Patients and Methods

The demographic and clinical characteristics of AYAs patients with cancer including age, sex, education status, marital status, social history including smoking status, alcohol use, and financial support, were recorded. Assessment of psychological distress of patients using the NCCN DT was performed at the three time points over a period of 3 months.

The NCCN Distress Thermometer (DT)

The DT was developed by the National Comprehensive Cancer Network (NCCN) to measure cancer patients' distress. The DT is a single-item, which has a scale from 0 to 10 for patients to rate their distress level.18 Patients rate their distress level, on a scale from 0 to 10, with 0 being the lowest and 10 being the highest. In addition, it included a list of problems that were categorized into five domains for selection by patients: (1) practical, (2) family, (3) emotional, (4) spiritual or religious, and (5) physical. The DT was chosen due to its ease and specificity. A score of ≥ 4 corresponds to clinically significant distress in cancer patients.

Statistical Analysis

Data were analyzed using the Statistical Package for The Social Sciences (SPSS) software, version 23.0. The normal distribution of quantitative data was determined by the Shapiro–Wilk test. Independent sample t-test was used for comparison of two independent groups. Chi-square test was used to analyze differences between categorical variables from two independent groups. A p-value<0.05 was considered statistically significant.

Results

Demographic Characteristics

In total, 259 patients (188 women and 71 men) were recruited into the study. The median age of the patients was 34 years. Seventy-one (27.4%) were ≤ 24 years old and 188 (72.6%) were>24 years old. The proportion of patients with stage II, III, and IV disease was 19.3%, 63.3%, and 17.4%, respectively (Table 1). The majority of patients had breast cancer (30.9%), followed by germ cell cancer (14.3%), ovarian cancer (9.7%), colon cancer (8.9%), Ewing sarcoma (7.7%), osteosarcoma (6.2%), lung cancer (5.8%), and cervical cancer (5.0%) (Fig. 1).

Types of cancer.
Fig. 1: Types of cancer.
Table 1
Demographic characteristics

Parameters

Number of patients (N=259)

Age (y), Median (SD); Range

31.0 (7.1); 34.0 (15.0–39.0)

Age groups (y)

≤24

71 (27.4)

>24

188 (72.6)

Sex

Women

162 (62.5)

Men

97 (37.5)

Living circumstance

Rural

93 (35.9)

Urban

166 (64.1)

Education status

Secondary school

19 (7.3)

Undergraduate

170 (65.6)

Postgraduate

70 (27.0)

Marital status

Married

194 (74.9)

Unmarried

65 (25.1)

Addiction

Non-alcoholic

163 (62.9)

Tobacco

57 (22.0)

Tobacco and alcohol

27 (10.4)

Alcohol

12 (4.6)

Financial support

230 (88.8)

Income per annum

<10,000

80 (30.9)

10,000–25,000

80 (30.9)

>25,000

99 (38.3)

Disease stage

II

50 (19.3)

III

164 (63.3)

IV

45 (17.4)

Note: Data shown as n (%) unless otherwise specified

Cancer Incidence by Age

Among AYA patients aged ≤ 24 years, germ cell tumor (40.8%), Ewing sarcoma (25.4%), and osteosarcoma (22.5%) were the most common types of cancer. In AYA patients aged >24 years, breast cancer (42.6%) was the most common cancer (Table 2).

Table 2
Cancer incidence by age

Type of cancer

≤24 years

(n=71)

>24 years

(n=188)

Bone sarcoma

16 (22.5)

-

Brain tumor

2 (2.8)

2 (1.1)

Ewing sarcoma

18 (25.4)

2 (1.1)

Germ cell tumor

29 (40.8)

8 (4.3)

Ovarian cancer

6 (8.5)

19 (10.1)

Breast cancer

-

80 (42.6)

Cervical cancer

-

13 (6.9)

Colon cancer

-

23 (12.2)

Gallbladder cancer

-

3 (1.6)

Hepatocellular carcinoma

-

3 (1.6)

Head and neck cancer

-

8 (4.3)

Lung cancer

-

15 (8.0)

Stomach cancer

-

9 (4.8)

Urinary bladder cancer

-

3 (1.6)

Note: Data shown as n (%).

Trajectory of Distress Level Over Three Time Points

The average distress score at the age ≤ 24 years was the highest (6.7) at T1, followed by those measured at T2 (2.6) and T3 (1.1). The average distress score at the age>24 years was the highest (6.6) at T1, followed by those measured at T2 (2.6) and T3 (1.2). The distress score decreased through the treatment period in both the age groups. Distress levels at all time points did not differ among patients with different disease status. The average difference in distress score between T1 and T2, T1 and T3, and T2 and T3 was 0.048 (p=0.875), 0.029 (p=0.905), and 0.036 (p=0.763), respectively (Table 3).

Table 3
Trajectory of distress level over three time points

Parameters

T1

T2

T3

P-value

Between T1 and T2

Between T1 and T3

Between T2 and T3

Mean (SD)

P-value

Mean (SD)

P-value

Mean (SD)

P-value

Distress score

Age ≤24 years

6.7 (2.1)

2.6 (1.7)

1.1 (0.9)

0.336

0.048 (0.3)

0.875

0.029 (0.2)

0.905

0.036 (0.1)

0.763

Age >24 years

6.6 (2.2)

2.6 (1.8)

1.2 (0.9)

0.641

Note: Data shown as mean (SD).

T1: at diagnosis; T2: 1 month after diagnosis; T3: 3 months after diagnosis.

Analysis of the Distress Thermometer Problems List across the Three Time Points

At each time point, most problems belonged to the practical and emotional domains. At T1, theses were worry (100%), nervousness (93.1%), sadness (93.1%), transportation (88.8%), sleep (88.4%), depression (86.5%), financial support (86.5%), loss of interest in daily activity (78.4%), pain (71.4%), appearance (49.8%), and loss of sexual interest (49.4%).

At T2, major problems included nausea (82.2%), transportation (77.6%), fatigue (70.7%), depression (58.7%), sleep (55.6%), indigestion (53.7%), sadness (52.9%), worry (52.1%), loss of interest in daily activity (50.2%), and diarrhea (50.6%).

At T3, major problems identified, included worry (81.5%), transportation (81.1%), fatigue (78.0%), nervousness (74.5%), sadness (61.0%), nausea (51.7%), and financial support (52.1%).

Among AYA patients >24 years old, worry (100.0%), nervousness (94.1%), sadness (94.1%), transportation (89.4%), and sleep (87.2%) were the top five causes of distress.

Among AYAs ≤ 24 years old, the top five causes were worry (100.0%), financial support (91.5%), sleep (91.5%), nervousness (90.1%), and sadness (90.1%).

The distress significantly changes with time included childcare, work/school, dressing, indigestion, loss of sexual interest, dry skin, and tingling hands/feet (p<0.001, each), change in urination (p=0.008), eating (p=0.041), and swelling (p=0.030) (Table 4).

Table 4
Analysis of the distress thermometer problems list across the three time points

Parameter

All patients (N=259)

≤24 years (n=71)

>24 years (n=188)

T1

T2

T3

P value

T1

T2

T3

T1

T2

T3

Practical problems

Childcare

104 (40.2)

81 (31.3)

75 (29.0)

<0.001a,b,c

10 (14.1)

7 (9.9)

5 (7.0)

94 (50.0)

74 (39.4)

70 (37.2)

Financial support

224 (86.5)

123 (47.5)

135 (52.1)

0.143a, 0.721b, 0.404c

65 (91.5)

35 (49.3)

40 (56.3)

159 (84.6)

88 (46.8)

95 (50.5)

Transportation

230 (88.8)

201 (77.6)

210 (81.1)

0.643a, 0.300b, 0.577c

62 (87.3)

52 (73.2)

56 (78.9)

168 (89.4)

149 (79.3)

154 (81.9)

Work/school

118 (45.6)

116 (44.8)

116 (44.8)

<0.001a,b,c

50 (70.4)

48 (67.6)

48 (67.6)

68 (36.2)

68 (36.2)

68 (36.2)

Emotional problems

Depression

224 (86.5)

152 (58.7)

110 (42.5)

0.869a, 0.637b, 0.278c

61 (85.9)

40 (56.3)

34 (47.9)

163 (86.7)

112 (59.6)

76 (40.4)

Nervousness

241 (93.1)

107 (41.3)

193 (74.5)

0.258a, 0.925b, 0.542c

64 (90.1)

29 (40.8)

51 (71.8)

177 (94.1)

78 (41.5)

142 (75.5)

Sadness

241 (93.1)

137 (52.9)

158 (61.0)

0.258a, 0.215b, 0.129c

64 (90.1)

42 (59.2)

38 (53.5)

177 (94.1)

95 (50.5)

120 (63.8)

Worry

259 (100.0)

135 (52.1)

211 (81.5)

0.998b, 0.763c

71 (100.0)

37 (52.1)

57 (80.3)

188 (100.0)

98 (52.1)

154 (81.9)

Loss of interest in daily activity

203 (78.4)

130 (50.2)

55 (21.2)

0.905a, 0.116b, 0.295c

56 (78.9)

30 (42.3)

12 (16.9)

147 (78.2)

100 (53.2)

43 (22.9)

Physical problems

Appearance

129 (49.8)

126 (48.6)

124 (47.9)

0.859a, 0.898b, 0.779c

36 (50.7)

35 (49.3)

35 (49.3)

93 (49.5)

91 (48.4)

89 (47.3)

Change in urination

41 (15.8)

30 (11.6)

17 (6.9)

0.046a, 0.066b, 0.008c

6 (8.5)

4 (5.6)

2 (2.8)

35 (18.6)

26 (13.8)

15 (8.0)

Diarrhea

51 (19.7)

131 (50.6)

28 (10.8)

0.005a, 0.028b, 0.552c

6 (8.5)

28 (39.4)

9 (12.7)

45 (23.9)

103 (54.8)

19 (10.1)

Eating

69 (26.6)

122 (47.1)

99 (38.2)

0.001a, 0.018b, 0.041c

8 (11.3)

25 (35.2)

20 (28.2)

61 (32.4)

97 (51.6)

79 (42.0)

Fatigue

108 (41.7)

183 (70.7)

202 (78.0)

0.462a, 0.202b, 0.071c

27 (38.0)

46 (64.8)

50 (70.4)

81 (43.1)

137 (72.9)

152 (80.9)

Feeling Swollen

51 (19.7)

32 (12.4)

18 (7.4)

0.036a, 0.043b, 0.030c

8 (11.3)

4 (5.6)

1 (1.5)

43 (22.9)

28 (14.9)

17 (9.7)

Indigestion

79 (30.5)

139 (53.7)

56 (21.6)

<0.001a,b,c

6 (8.5)

25 (35.2)

4 (5.6)

73 (38.8)

114 (60.6)

52 (27.7)

Nausea

12 (4.6)

213 (82.2)

134 (51.7)

0.848a, 0.557b, 0.187c

3 (4.2)

60 (84.5)

32 (45.1)

9 (4.8)

153 (81.4)

102 (54.3)

Pain

185 (71.4)

124 (47.9)

46 (17.8)

0.597a, 0.404b, 0.887c

49 (69.0)

31 (43.7)

13 (18.3)

136 (72.3)

93 (49.5)

33 (17.6)

Loss of sexual interest

128 (49.4)

78 (30.1)

53 (20.5)

<0.001a,b,c

6 (8.5)

6 (8.5)

4 (5.6)

122 (64.9)

72 (38.3)

49 (26.1)

Dry skin

66 (25.5)

53 (20.5)

43 (16.6)

<0.001a,b,c

37 (52.1)

28 (39.4)

24 (33.8)

29 (15.4)

25 (13.3)

19 (10.1)

Sleep

229 (88.4)

144 (55.6)

59 (22.8)

0.333a, 0.669b, 0.204c

65 (91.5)

41 (57.7)

20 (28.2)

164 (87.2)

103 (54.8)

39 (20.7)

Tingling hands/feet

40 (15.4)

107 (41.3)

107 (41.3)

<0.001a,b,c

36 (50.7)

48 (67.6)

48 (67.6)

4 (2.1)

59 (31.4)

59 (31.4)

Note: Data shown as n (%).

T1: at diagnosis; T2: 1 month after diagnosis; T3: 3 months after diagnosis.

Discussion

The present study evaluated psychological distress among Indian AYA cancer patients. Distress scores in both groups (≤ 24 and>24 years) were higher at T1 than at T2 and T3. Most of the reported problems among AYA patients were practical and emotional in nature. Among AYAs older than 24 years, worry, nervousness, sadness, transportation, and sleep were the top five problems, while in the age group of ≤ 24 years, worry, financial support, sleep, nervousness, and sadness predominated. The most prevalent problem across time-points for patients was worry (emotional problem). Several psychological problems included childcare, work/school, appearance, indigestion, loss of sexual interest, dry skin, and tingling hands/feet (p<0.001, each) were significantly associated with higher distress scores.

A population-based study on a large population (n=3,199) reported higher prevalence of psychological disorders in patients of the younger age groups.19 Massetti et al reported that mental disorders are more common in AYA cancer patients aged 18 to 29 years.20 The American AYA HOPE study collaborative group concluded that AYAs with cancer survivors exhibited significantly higher risk for developing poor psychosocial outcomes compared with the general population.21 The present study also indicates a high prevalence of distress among AYA cancer patients.

In the present study, the distress scores were the highest at the commencement of treatment (T1) and tended to decrease thereafter (at T2 and T3). Other studies have shown that distress was high at diagnosis and reduced after diagnosis.2223

Many studies have been previously reported that distress is fairly high at diagnosis and during treatment in AYAs.2425 A longitudinal study evaluated that about half of the AYAs experienced significant distress at diagnosis and nature of illness, difficulty, and uncertainty in treatment create a wide range of psychological concerns in AYAs with cancer.26

A meta-analysis reported that depression is associated with a high incidence of cancer incidence and mortality.27 Therefore, interventions in the psychological management of cancer treatment, early after diagnosis can prevent escalation of distress and improve treatment outcomes.

In the present study, the emotional problem was found in most of the patients. At the time of diagnosis, almost all patients reported being worried, and more than a quarter of patients reported depression, nervousness, sadness, and loss of interest in daily activity Untreated anxiety and depression can have a negative impact on life with lasting consequences including reduced survival. Trained nurses, counselors, and navigators in communication and assessment skills to recognize anxiety and depression in cancer patients will be helpful in identifying different types of distress.28

Financial problems are generally due to low family income and lack of insurance coverage are consistent with other studies.29 The majority of the patients reported problems such as a lack of financial support and lack of health insurance. Poor availability of transport services posed a difficulty in reaching hospital for treatment from rural areas.

Among AYAs of different age groups (≤ 24 and>24 years old), worry, nervousness, sadness, and sleep were the common. Moreno-Smith et al reported fatigue, nervousness, and sleep difficulties were associated with poor disease outcomes.30 The early recognition of these emotional problems may be helpful in diagnosing depression in cancer patients.

The concept of symptom burden is commonly used in medical and psychological literature. It denotes symptoms experienced by patients as a result of the chronic or terminal illnesses or associated treatments.31 Patients with advanced cancer experienced poor psychological and physical outcomes, which was associated with poorer HRQoL.32 It is a recommended metric of psychological and physical status among patients affected by severe and chronic diseases, including cancer.3233

Chan et al evaluated the symptom burden and HRQoL using the DT. In this study, an association between DT score and problem list items was statistically significant. Several psychological and physical problems such as worry, decreased sexual interest, and constipation were significantly associated with distress scores. Chan et al20 demonstrated a significant relationship between several RSCL symptoms including worry, depressed mood, and nervousness, and DT.34

Other studies provide evidence supporting an association of anxiety/depressive symptoms and fatigue with the cognitive function observed in patients with cancer.35 Various screening tools were designed to measure stress levels in patients with cancer. The use of DT will help clinicians design future management strategies for cancer in adolescent and young adult population.

Conclusion

Distress is a psychological entity hitherto unquantified in the management of cancer patients,. We have made the first assessment of distress among the vulnerable and dynamic demography of AYA cancer. AYAs experience some level of distress associated with the cancer diagnosis, effects of the disease, treatment regardless of the stage and various transitions throughout the trajectory of the disease. Distress can be a reason for non-adherence to cancer treatment. Common types of distress that were identified in Indian AYAs with cancer were worry, nervousness, sadness, and sleep disturbance. Patient should be assessed to ascertain their level of distress at the initial visit and at appropriate intervals. Clinicians should recognize, monitor, document, and treat distress level at all stages of disease. The DT is an easy and useful tool for the assessment of psychological distress in AYA cancers. Early identification of distress burden with the DT leads to effective interventions in patients with cancer which could improve outcomes including survival in AYAs with cancer in India.

References

  1. , , , , . Working beyond the patient and cancer for adolescents and young adults. Eur J Cancer Care (Engl). 2018;27(06):e12967.
    [Google Scholar]
  2. , , , , , . Epidemiology of cancers among adolescents and young adults from a tertiary cancer center in Delhi. Indian J Med Paediatr Oncol. 2016;37(02):90-94.
    [Google Scholar]
  3. , . Population Enumeration Data; Five-Year Age Group Data C-14 Tables. Accessed January 20, 2022, at: http://www.censusindia.gov.in/2011census/C-series/C-14.html
    [Google Scholar]
  4. , . The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Oncol. 2022;23(01):27-52.
    [Google Scholar]
  5. , , , , , . Needs and lifestyle challenges of adolescents and young adults with cancer. Clin J Oncol Nurs. 2015;19(06):675-681.
    [Google Scholar]
  6. , . Accessed January 20, 2022, at:
  7. , , , et al . Incidence, risk factors, and mortality associated with second malignant neoplasms among survivors of adolescent and young adult cancer. JAMA Netw Open. 2019;2(06):e195536.
    [Google Scholar]
  8. , , , , , , . Increased risk of second malignant neoplasms in adolescents and young adults with cancer. Cancer. 2016;122(01):116-123.
    [Google Scholar]
  9. , , , et al . Cardiovascular disease risk profiles in survivors of adolescent and young adult (AYA) cancer: the Kaiser Permanente AYA Cancer Survivors Study. J Clin Oncol. 2016;34(14):1626-1633.
    [Google Scholar]
  10. , , , , , . Self-perceived physical attractiveness in relation to scars among adolescent and young adult cancer survivors: a population-based study. J Adolesc Young Adult Oncol. 2018;7(03):358-366.
    [Google Scholar]
  11. , , , et al . Prevalence and determinants of psychological distress in adolescent and young adult patients with cancer: a multicenter survey. Asia Pac J Oncol Nurs. 2021;8(03):314-321.
    [Google Scholar]
  12. , , , et al , . Positive and negative psychosocial impact of being diagnosed with cancer as an adolescent or young adult. Cancer. 2012;118(20):5155-5162.
    [Google Scholar]
  13. , , , , , , . “You're too young for this”: adolescent and young adults' perspectives on cancer survivorship. J Psychosoc Oncol. 2012;30(02):260-279.
    [Google Scholar]
  14. , , , . The NCCN guideline for distress management: a case for making distress the sixth vital sign. J Natl Compr Canc Netw. 2007;5(01):3-7.
    [Google Scholar]
  15. , , . Mental disorder screening on cancer patients before and after radiotherapy and at the 1-month follow-up. Support Care Cancer. 2018;26(03):813-821.
    [Google Scholar]
  16. , , , et al . Trajectories of psychological distress in adolescent and young adult patients with cancer: a 1-year longitudinal study. J Clin Oncol. 2013;31(17):2160-2166.
    [Google Scholar]
  17. , , , . Reliability and concurrent validity of the Palliative Outcome Scale, the Rotterdam Symptom Checklist, and the Brief Pain Inventory. J Palliat Med. 2013;16(08):867-874.
    [Google Scholar]
  18. , , , et al . The diagnostic role of a short screening tool–the distress thermometer: a meta-analysis. Support Care Cancer. 2014;22(07):1741-1755.
    [Google Scholar]
  19. , , , et al . The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies. Br J Cancer. 2019;120(08):840-847.
    [Google Scholar]
  20. , , , , , . Mental health problems and cancer risk factors among young adults. Am J Prev Med. 2017;53:S30-S39.
    [Google Scholar]
  21. , , , et al , . Unmet support service needs and health-related quality of life among adolescents and young adults with cancer: the AYA HOPE study. Front Oncol. 2013;3(75):75.
    [Google Scholar]
  22. , , , . Health-related quality of life, anxiety and depression among adolescents and young adults with cancer: a prospective longitudinal study. Eur J Cancer. 2007;43(13):1952-1958.
    [Google Scholar]
  23. , , , . Aspects of quality of life, anxiety, and depression among persons diagnosed with cancer during adolescence: a long-term follow-up study. Eur J Cancer. 2010;46(06):1062-1068.
    [Google Scholar]
  24. , , , , , , . Mental distress and health care use among survivors of adolescent and young adult cancer: a cross-sectional analysis of the National Health Interview Survey. Cancer. 2017;123(05):869-878.
    [Google Scholar]
  25. , , , et al . Psychological distress and unsatisfied need for psychosocial support in adolescent and young adult cancer patients during the first year following diagnosis. Psychooncology. 2014;23(11):1267-1275.
    [Google Scholar]
  26. , , , et al . Assessment of psychological distress among Asian adolescents and young adults (AYA) cancer patients using the distress thermometer: a prospective, longitudinal study. Support Care Cancer. 2018;26(09):3257-3266.
    [Google Scholar]
  27. , , , et al . Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry. 2020;25(07):1487-1499.
    [Google Scholar]
  28. , , . The management of psychological issues in oncology. Clin Adv Hematol Oncol. 2016;14(12):999-1009.
    [Google Scholar]
  29. , , . Insurance coverage and financial burden for families of children with special health care needs. Ambul Pediatr. 2006;6(04):204-209.
    [Google Scholar]
  30. , , , . Impact of stress on cancer metastasis. Future Oncol. 2010;6(12):1863-1881.
    [Google Scholar]
  31. , . Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr (37):16-21.
    [Google Scholar]
  32. , , , et al . Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer. Health Qual Life Outcomes. 2016;14:52.
    [Google Scholar]
  33. , , , et al . Radiation therapy for patients with bone metastasis from uterine cervical Cancer: its role and optimal radiation regimen for palliative care. Anticancer Res. 2018;38(02):1033-1040.
    [Google Scholar]
  34. , , , , , , . Symptom burden and medication use in adult sarcoma patients. Support Care Cancer. 2015;23(06):1709-1717.
    [Google Scholar]
  35. , , , , , , . Self-reported cognitive outcomes among adolescent and young adult patients with noncentral nervous system cancers. Psychooncology. 2020;29(08):1355-1362.
    [Google Scholar]
Show Sections